Literature DB >> 19151012

Discordance between microneurographic and heart-rate spectral indices of sympathetic activity in pulmonary arterial hypertension.

C L McGowan1, J S Swiston, C F Notarius, S Mak, B L Morris, P E Picton, J T Granton, J S Floras.   

Abstract

OBJECTIVES: To determine, in patients with pulmonary arterial hypertension (PAH), whether there is a relationship: (1) between sympathetic nerve firing rate and spectral indices of sympathetic neural heart rate modulation; and (2) between heart rate variability (HRV) and right atrial pressure, a stimulus to sinoatrial node stretch.
DESIGN: Characterisation of patients and healthy controls.
SETTING: Teaching hospital-based study. PATIENTS: 9 PAH patients without elevated pulmonary capillary wedge pressure and nine age-matched control subjects.
INTERVENTIONS: Heart rate (HR) and muscle sympathetic nerve activity (MSNA) were recorded during 10 min of supine rest in both PAH patients studied after right heart catheterisation, and healthy volunteers. Coarse-graining spectral analysis determined HR spectral power. MAIN OUTCOME MEASURES: (1) Low-frequency (PL) spectral component of HRV; (2) MSNA burst frequency; and in PAH patients: (3) right atrial pressure.
RESULTS: MSNA burst frequency was higher in PAH patients (48 (24) and 29 (11) bursts/min, respectively; mean (SD); p = 0.05), whereas total power (p = 0.01), its fractal (p<0.01) and harmonic (p = 0.04) components, and PL (p = 0.01) were all reduced. PL related inversely to both MSNA burst frequency (r = -0.86, p = 0.005) and right atrial systolic pressure (r = -0.77, p = 0.04).
CONCLUSIONS: Thus, in PAH (as in patients with left ventricular systolic dysfunction) loss of PL relates inversely to gain in MSNA burst frequency. Diminished sympathetic neural heart rate modulation and increased right atrial stretch may combine to attenuate HRV, an adverse prognostic marker.

Entities:  

Mesh:

Year:  2009        PMID: 19151012     DOI: 10.1136/hrt.2008.157115

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  10 in total

Review 1.  Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension.

Authors:  Marjorie Barrier; Jolyane Meloche; Maria Helena Jacob; Audrey Courboulin; Steeve Provencher; Sébastien Bonnet
Journal:  Cell Mol Life Sci       Date:  2012-03-25       Impact factor: 9.261

2.  Effects of isometric handgrip training dose on resting blood pressure and resistance vessel endothelial function in normotensive women.

Authors:  Mark B Badrov; Cassandra L Bartol; Matthew A DiBartolomeo; Philip J Millar; Nancy H McNevin; Cheri L McGowan
Journal:  Eur J Appl Physiol       Date:  2013-04-16       Impact factor: 3.078

Review 3.  Emerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part II: Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial Hypertension.

Authors:  Bradley A Maron; Jane A Leopold
Journal:  Circulation       Date:  2015-06-09       Impact factor: 29.690

Review 4.  Low-frequency power of heart rate variability is not a measure of cardiac sympathetic tone but may be a measure of modulation of cardiac autonomic outflows by baroreflexes.

Authors:  David S Goldstein; Oladi Bentho; Mee-Yeong Park; Yehonatan Sharabi
Journal:  Exp Physiol       Date:  2011-09-02       Impact factor: 2.969

5.  Effects of exercise training on heart rate variability in children and adolescents with pulmonary arterial hypertension: a pilot study.

Authors:  Jannos Siaplaouras; Marc Frerix; Anita Apitz; David Zöller; Christian Apitz
Journal:  Cardiovasc Diagn Ther       Date:  2021-08

6.  Valsalva Maneuver in Pulmonary Arterial Hypertension: Susceptibility to Syncope and Autonomic Dysfunction.

Authors:  Philip L Mar; Victor Nwazue; Bonnie K Black; Italo Biaggioni; André Diedrich; Sachin Y Paranjape; James E Loyd; Anna R Hemnes; Ivan M Robbins; David Robertson; Satish R Raj; Eric D Austin
Journal:  Chest       Date:  2016-01-13       Impact factor: 9.410

7.  Sympatho-Vagal Dysfunction in Patients with End-Stage Lung Disease Awaiting Lung Transplantation.

Authors:  Eleonora Tobaldini; Gabriel D Rodrigues; Giorgio Mantoan; Alice Monti; Giulia Coti Zelati; Camilla Cirelli; Paolo Tarsia; Letizia Corinna Morlacchi; Valeria Rossetti; Ilaria Righi; Mario Nosotti; Pedro Paulo da S Soares; Nicola Montano; Stefano Aliberti; Francesco Blasi
Journal:  J Clin Med       Date:  2020-04-17       Impact factor: 4.241

8.  Heart rate variability in pulmonary hypertension with and without sleep apnea.

Authors:  Carolina Gonzaga Carvalho; Richard Bresler; Ying Xuan Zhi; Hisham Alshaer; John T Granton; Clodagh M Ryan
Journal:  Heliyon       Date:  2019-07-03

Review 9.  Mechano-sensitivity of cardiac pacemaker function: pathophysiological relevance, experimental implications, and conceptual integration with other mechanisms of rhythmicity.

Authors:  T Alexander Quinn; Peter Kohl
Journal:  Prog Biophys Mol Biol       Date:  2012-08-21       Impact factor: 3.667

Review 10.  Neurohormonal modulation in pulmonary arterial hypertension.

Authors:  Eva L Peters; Harm Jan Bogaard; Anton Vonk Noordegraaf; Frances S de Man
Journal:  Eur Respir J       Date:  2021-10-28       Impact factor: 16.671

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.